An Iranian knowledge-based company has introduced a nanotechnology-based kit that uses lateral flow assay technology to ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Dublin, Feb. 21, 2024 (GLOBE NEWSWIRE) -- The "Lateral Flow Assay Test Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, ...

A 2026 narrative review finds that rapid point-of-care technologies can detect pathogens and resistance markers closer to ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.

In this interview, News-Medical talks to Hasret Altan-Martin from Sartorius about the ongoing emergence of lateral flow assays in diagnostics. Before the COVID-19 pandemic, the pregnancy test was the ...

According to MarketsandMarkets™, the Lateral Flow Assays Market is projected to reach USD 13.52 billion by 2031 from USD 9.14 billion in 2026, at a CAGR of 8.1% during the forecast period.

SHERIDAN, Wyo., Sept. 22, 2026 /PRNewswire/ -- The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...

Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...